Glimepiride Tablet
Product Images NDC 72789-370

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 72789-370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789370 Label (72789370)

Glimepiride USP 2 mg oral tablet label from PD-Rx Pharmaceuticals, Inc. The label includes the NDC 72789-370-30 and indicates the package contains 30 tablets. It features dosage strength, reorder number, lot number, and expiration date (04/2025). A warning to keep out of reach of children is present, along with spaces for dosage instructions and reporting side effects to the FDA.*

FDA Label Image

Chemical Structure (Glimepiride Str)

Chemical structure of Glimepiride showing its molecular components including a sulfonylurea group and a piperidine ring, consistent with its identity as the active ingredient in the oral tablet formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.